Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APASL Post-COVID-19 Vaccination Liver Injury (APCOVLI Study)

NCT05470894 is registered in ClinicalTrials.gov with Humanity & Health Medical Group Limited as lead sponsor.

NCT NCT05470894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APASL Post-COVID-19 Vaccination Liver Injury (APCOVLI Study)
Lead sponsor
Humanity & Health Medical Group Limited
Phase
Observational
Overall status
Completed
Start date
September 5, 2022
Completion date
December 31, 2024
Enrollment
379 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

subjects after covid-19 vaccination